Page 31 - Exact Sciences News Today

Within the last quarter, Exact Sciences EXAS has observed the following analyst ratings: These 7 analysts have an average price target of $102.0 versus the…

TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET GDP, Personal Consumption, Core PCE Price Index, Weekly Jobless Claims; 9:00ET Fed's Goolsbee speaks; 10:00ET Pending Home Sales; 11:00ET Kansas City Fed Mfg. Activity; 1:00ET Fed's Cook speaks; 3:00ET Mexico Rate Decision; 3:30ET Fed's Barkin speaks; 4:00ET Fed’s Powell host town hall

TUCSON (KVOA) — Tickets and hospitality packages are now on sale for the 2024 Cologuard Classic.

You aren't too late to the party.

NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET             Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with...

Woodall's Campground Magazine Wis. Campground Set to Host Cancer Survivors Event Industry News

Bioscience momentum in Arizona is continuing to build — especially when it comes to bioscience building and construction.

National Institute of Diabetes and Digestive and Kidney Diseases to Occupy Entire 7th Floor of 850 PBCProximity to University Research, Talent, an...

ARK Investment Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 37.1% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,155,098 shares of the medical research company’s stock after selling 4,224,089 shares during the period. […]